Home LiteratureArticle Details
PMID: 12623123 Published · ppublish English Journal Article

Tumor necrosis factor alpha-induced apoptosis in astrocytes is prevented by the activation of P2Y6, but not P2Y4 nucleotide receptors.

Biochemical pharmacology ·Vol. 65 ·No. 6 ·2003-03-15 ·Pages 923-31

Kim SG, Soltysiak KA, Gao ZG, Chang TS, Chung E, Jacobson KA

Abstract

The physiological role of the uracil nucleotide-preferring P2Y(6) and P2Y(4) receptors is still unclear, although they are widely distributed in various tissues. In an effort to identify their biological functions, we found that activation by UDP of the rat P2Y(6) receptor expressed in 1321N1 human astrocytes significantly reduced cell death induced by tumor necrosis factor alpha (TNF alpha). This effect of UDP was not observed in non-transfected 1321N1 cells. Activation of the human P2Y(4) receptor expressed in 1321N1 cells by UTP did not elicit this protective effect, although both receptors were coupled to phospholipase C. The activation of P2Y(6) receptors prevented the activation of both caspase-3 and caspase-8 resulting from TNF alpha exposure. Even a brief (10-min) incubation with UDP protected the cells against TNF alpha-induced apoptosis. Interestingly, UDP did not protect the P2Y(6)-1321N1 cells from death induced by other methods, i.e. oxidative stress induced by hydrogen peroxide and chemical ischemia. Therefore, it is suggested that P2Y(6) receptors interact rapidly with the TNF alpha-related intracellular signals to prevent apoptotic cell death. This is the first study to describe the cellular protective role of P2Y(6) nucleotide receptor activation.

MeSH Terms
Apoptosis/physiology Astrocytes/drug effects,metabolism,pathology Humans Protective Agents/pharmacology Receptors, Purinergic P2/metabolism Transfection Tumor Cells, Cultured Tumor Necrosis Factor-alpha/physiology Uridine Diphosphate/pharmacology
Chemicals
Protective Agents Receptors, Purinergic P2 Tumor Necrosis Factor-alpha purinoceptor P2Y4 purinoceptor P2Y6 Uridine Diphosphate
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Kim Seong G
Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, Bldg. 8A, Rm. B1A-19, National Institutes of Health, Bethesda, MD 20892-0810, USA.
Soltysiak Kelly A
Gao Zhan-Guo
Chang Tong-Shin
Chung Eunju
Jacobson Kenneth A
References (50)
50 references, click to expand
  1. Pharmacologic stimulation of adenosine A2 receptor supplants ischemic preconditioning in providing ischemic tolerance in rat livers.
    Surgery. 1999 Nov;126(5):945-54 PMID: 10568196
  2. Expression of the P2Y6 purinergic receptor in human T cells infiltrating inflammatory bowel disease.
    Lab Invest. 1998 Nov;78(11):1375-83 PMID: 9840612
  3. Glucose deprivation and chemical hypoxia: neuroprotection by P2 receptor antagonists.
    Neurochem Int. 2001 Mar;38(3):189-97 PMID: 11099776
  4. Adenosine modulation of D-[3H]aspartate release in cultured retina cells exposed to oxidative stress.
    Neurochem Int. 2000 Mar;36(3):255-65 PMID: 10676861
  5. MAPK/ERK overrides the apoptotic signaling from Fas, TNF, and TRAIL receptors.
    J Biol Chem. 2001 May 11;276(19):16484-90 PMID: 11278665
  6. Chronic administration of adenosine A3 receptor agonist and cerebral ischemia: neuronal and glial effects.
    Eur J Pharmacol. 1999 Feb 19;367(2-3):157-63 PMID: 10078988
  7. Site of action of suramin and reactive blue 2 in preventing neuronal death induced by dequalinium.
    J Neurosci Res. 2000 Dec 1;62(5):692-9 PMID: 11104507
  8. Adenosine and selective A(2A) receptor agonists reduce ischemia/reperfusion injury of rat liver mainly by inhibiting leukocyte activation.
    J Pharmacol Exp Ther. 2000 Sep;294(3):1034-42 PMID: 10945856
  9. A novel pharmacological approach to treating cardiac ischemia. Binary conjugates of A1 and A3 adenosine receptor agonists.
    J Biol Chem. 2000 Sep 29;275(39):30272-9 PMID: 10887176
  10. Differential regulation of the uridine nucleotide-activated P2Y4 and P2Y6 receptors. SER-333 and SER-334 in the carboxyl terminus are involved in agonist-dependent phosphorylation desensitization and internalization of the P2Y4 receptor.
    J Biol Chem. 2001 Apr 13;276(15):11939-48 PMID: 11114308
  11. Induction of proliferation and apoptotic cell death via P2Y and P2X receptors, respectively, in rat glomerular mesangial cells.
    Kidney Int. 2000 Mar;57(3):949-58 PMID: 10720948
  12. Expression of functional P2-purinergic receptors in primary cultures of human colorectal carcinoma cells.
    Biochem Biophys Res Commun. 1998 Oct 29;251(3):811-7 PMID: 9790992
  13. Characterisation of subtypes of the P2X and P2Y families of ATP receptors in the foetal human heart.
    Life Sci. 1998;62(8):697-703 PMID: 9489506
  14. A1 adenosine receptor antagonists block ischemia-reperfusion injury of the lung.
    Am J Physiol. 1995 Jun;268(6 Pt 1):L1036-46 PMID: 7611426
  15. NF-kappa B activation results in rapid inactivation of JNK in TNF alpha-treated Ewing sarcoma cells: a mechanism for the anti-apoptotic effect of NF-kappa B.
    Oncogene. 2001 Jul 19;20(32):4365-72 PMID: 11466617
  16. Tumour necrosis factors receptor associated signalling molecules and their role in activation of apoptosis, JNK and NF-kappaB.
    Ann Rheum Dis. 2000 Nov;59 Suppl 1:i6-16 PMID: 11053079
  17. p53-Independent induction of Fas and apoptosis in leukemic cells by an adenosine derivative, Cl-IB-MECA.
    Biochem Pharmacol. 2002 Mar 1;63(5):871-80 PMID: 11911839
  18. Evidence that the p2y3 receptor is the avian homologue of the mammalian P2Y6 receptor.
    Mol Pharmacol. 1998 Sep;54(3):541-6 PMID: 9730913
  19. UTP evokes noradrenaline release from rat sympathetic neurons by activation of protein kinase C.
    J Neurochem. 2001 May;77(3):876-85 PMID: 11331416
  20. P2Y(6) nucleotide receptor mediates monocyte interleukin-8 production in response to UDP or lipopolysaccharide.
    J Biol Chem. 2001 Jul 13;276(28):26051-6 PMID: 11349132
  21. Receptors for purines and pyrimidines.
    Pharmacol Rev. 1998 Sep;50(3):413-92 PMID: 9755289
  22. Protective effects of renal ischemic preconditioning and adenosine pretreatment: role of A(1) and A(3) receptors.
    Am J Physiol Renal Physiol. 2000 Mar;278(3):F380-7 PMID: 10710542
  23. Adenosine A2 receptors reverse ischemia-reperfusion lung injury independent of beta-receptors.
    J Appl Physiol (1985). 1995 Mar;78(3):990-6 PMID: 7775345
  24. Opposing effects of adenosine on the survival of glial cells exposed to chemical ischemia.
    J Neurosci Res. 2000 Nov 15;62(4):539-46 PMID: 11070497
  25. Increase in cardiac P2X1-and P2Y2-receptor mRNA levels in congestive heart failure.
    Life Sci. 1999;65(11):1195-206 PMID: 10503935
  26. Involvement of protein kinase C-beta and ceramide in tumor necrosis factor-alpha-induced but not Fas-induced apoptosis of human myeloid leukemia cells.
    J Biol Chem. 1999 Aug 13;274(33):23526-34 PMID: 10438532
  27. Families of ion channels with two hydrophobic segments.
    Curr Opin Cell Biol. 1996 Aug;8(4):474-83 PMID: 8791456
  28. Uridine nucleotide selectivity of three phospholipase C-activating P2 receptors: identification of a UDP-selective, a UTP-selective, and an ATP- and UTP-specific receptor.
    Mol Pharmacol. 1996 Aug;50(2):224-9 PMID: 8700127
  29. Oxidative stress increases A1 adenosine receptor expression by activating nuclear factor kappa B.
    Mol Pharmacol. 1998 Apr;53(4):663-9 PMID: 9547356
  30. P2 purinoceptor-mediated control of rat cerebral (pial) microvasculature; contribution of P2X and P2Y receptors.
    J Physiol. 2000 Sep 1;527 Pt 2:315-24 PMID: 10970432
  31. The protective role of adenosine in inducing nitric oxide synthesis in rat liver ischemia preconditioning is mediated by activation of adenosine A2 receptors.
    Hepatology. 1999 Jan;29(1):126-32 PMID: 9862858
  32. Association of apoptosis with the inhibition of extracellular signal-regulated protein kinase activity in the tumor necrosis factor alpha-resistant ovarian carcinoma cell line UCI 101.
    Mol Carcinog. 1999 May;25(1):14-20 PMID: 10331740
  33. Tumor necrosis factor-alpha enhances hypoxia-reoxygenation-mediated apoptosis in cultured human coronary artery endothelial cells: critical role of protein kinase C.
    Cardiovasc Res. 1999 Jun;42(3):805-13 PMID: 10533621
  34. Adenosine-induced cell death: evidence for receptor-mediated signalling.
    Apoptosis. 1999 Jun;4(3):197-211 PMID: 14634282
  35. Cloning, expression, and chromosomal localization of the human uridine nucleotide receptor gene.
    J Biol Chem. 1995 Dec 29;270(52):30845-8 PMID: 8537335
  36. Apoptosis signaling by death receptors.
    Eur J Biochem. 1998 Jun 15;254(3):439-59 PMID: 9688254
  37. Adenosine nucleotides acting at the human P2Y1 receptor stimulate mitogen-activated protein kinases and induce apoptosis.
    J Biol Chem. 2001 May 11;276(19):16379-90 PMID: 11278310
  38. Pyrimidinoceptor potentiation of macrophage PGE(2) release involved in the induction of nitric oxide synthase.
    Br J Pharmacol. 2000 Jun;130(4):777-86 PMID: 10864883
  39. Expression of the human P2Y6 nucleotide receptor in normal placenta and gestational trophoblastic disease.
    Lab Invest. 1999 Feb;79(2):131-9 PMID: 10068202
  40. Effect of A1 adenosine receptor agonist upon cochlear dysfunction induced by transient ischemia.
    Hear Res. 1999 Oct;136(1-2):86-90 PMID: 10511627
  41. Regulation of cytosolic free calcium concentration by extracellular nucleotides in human hepatocytes.
    Am J Physiol. 1999 Jan;276(1 Pt 1):G164-72 PMID: 9886992
  42. Molecular cloning and characterization of the rat P2Y4 receptor.
    J Neurochem. 1998 Oct;71(4):1348-57 PMID: 9751165
  43. p38 mitogen-activated protein kinase mediates tumor necrosis factor-alpha-induced apoptosis in rat fetal brown adipocytes.
    Endocrinology. 2000 Dec;141(12):4383-95 PMID: 11108246
  44. Mitogenic and antiapoptotic actions of hepatocyte growth factor through ERK, STAT3, and AKT in endothelial cells.
    Hypertension. 2001 Feb;37(2 Pt 2):581-6 PMID: 11230338
  45. Effects of extracellular ATP on Fe(2+)-induced cytotoxicity in PC-12 cells.
    J Neurochem. 1994 Sep;63(3):895-902 PMID: 8051567
  46. Cloning and functional expression of a human uridine nucleotide receptor.
    J Biol Chem. 1995 Dec 29;270(52):30849-52 PMID: 8537336
  47. G protein-coupled receptors for ATP and other nucleotides: a new receptor family.
    Trends Pharmacol Sci. 1994 Mar;15(3):67-70 PMID: 8184488
  48. Molecular cloning and characterization of rat P2Y4 nucleotide receptor.
    Br J Pharmacol. 1998 Jun;124(3):428-30 PMID: 9647463
  49. Inhibition of JNK activation through NF-kappaB target genes.
    Nature. 2001 Nov 15;414(6861):313-7 PMID: 11713531
  50. Apical P2Y4 purinergic receptor controls K+ secretion by vestibular dark cell epithelium.
    Am J Physiol Cell Physiol. 2001 Jul;281(1):C282-9 PMID: 11401851
Article Info
Journal
Biochemical pharmacology
Abbr.
Biochem Pharmacol
ISSN
0006-2952
Published
2003-03-15
Pages
923-31
Language
English
Region
England
NLM ID
0101032
PMCID
PMC3402349
Subset
IM
Grants
Intramural NIH HHS · Z01 DK031116-20 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]